Knoll Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.34M | Hold |
1,121,524
| – | – | 3.09% | 13 |
|
|
2025
Q1 | $5.61M | Hold |
1,121,524
| – | – | 3.65% | 7 |
|
|
2024
Q4 | $8.09M | Hold |
1,121,524
| – | – | 5.21% | 5 |
|
|
2024
Q3 | $6.89M | Hold |
1,121,524
| – | – | 3.19% | 9 |
|
|
2024
Q2 | $7.46M | Buy |
1,121,524
+554,305
| +98% | +$3.69M | 5.03% | 5 |
|
|
2024
Q1 | $5.77M | Buy |
567,219
+367,219
| +184% | +$3.74M | 3.59% | 7 |
|
|
2023
Q4 | $2.25M | Buy |
+200,000
| New | +$2.25M | 1.86% | 15 |
|
|
2023
Q3 | – | Sell |
-173,864
| Closed | -$614K | – | 38 |
|
|
2023
Q2 | $614K | Hold |
173,864
| – | – | 0.74% | 24 |
|
|
2023
Q1 | $734K | Hold |
173,864
| – | – | 1.13% | 22 |
|
|
2022
Q4 | $2.86M | Hold |
173,864
| – | – | 6.45% | 3 |
|
|
2022
Q3 | $2.22M | Buy |
173,864
+40,886
| +31% | +$522K | 1.3% | 4 |
|
|
2022
Q2 | $1.56M | Hold |
132,978
| – | – | 0.89% | 7 |
|
|
2022
Q1 | $810K | Hold |
132,978
| – | – | 0.51% | 22 |
|
|
2021
Q4 | $1.22M | Hold |
132,978
| – | – | 0.67% | 15 |
|
|
2021
Q3 | $1.5M | Buy |
132,978
+82,978
| +166% | +$938K | 0.75% | 11 |
|
|
2021
Q2 | $1.11M | Hold |
50,000
| – | – | 0.58% | 21 |
|
|
2021
Q1 | $707K | Hold |
50,000
| – | – | 0.46% | 27 |
|
|
2020
Q4 | $564K | Buy |
+50,000
| New | +$564K | 0.38% | 21 |
|